MarketResearch.biz announces publication of its most recently generated research report titled, “Global D-Dimer Test Market by Testing Method (Point-of-care (POCT) Testing and Laboratory Testing (Coagulation Analyzers and Clinical Chemistry Analyzers)), Disease Type (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Disseminated Intravascular Coagulation (DIC)), End User (Hospitals, Clinics, Research Institutes, Diagnostics Laboratories, Home, Assisted Living Healthcare Facilities, and Ambulatory Surgical Centers), and by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Global Forecast to 2028.”, which offers a holistic view of the global D-dimer test market through systematic segmentation that covers every aspect of the target market. The first five-year cumulative revenue (2019–2023) is projected to be over US$ 12 Bn, which is estimated to increase considerably over the latter part of the five-year forecast period.
D-dimer is a protein fragments produced when a blood clot dissolves in the body. The level of D-dimer in the blood can rise when there is significant formation and breakdown of blood clots in the body. The D-dimer test is used to detect D-dimer in the blood.
Browse the full “D-dimer Test Market By Testing Method, By Disease Type (Deep Vein Thrombosis, Pulmonary Embolism, And Other), By End User (Hospitals, Clinics, Research Institutes, And Others), And Region – Global Forecast To 2028” report at https://marketresearch.biz/report/d-dimer-test-market/
Global D-Dimer Test Market: Market Dynamics
Increasing prevalence of thromboembolic disease owing to aging, prolonged immobility, and others is a major factor driving growth of the target market. In addition, increasing geriatric population, incidence rate and mortality rate of serious blood clotting disorders across the globe are among the other factors expected to drive growth of the target market in the next coming years. Furthermore, increasing adoption of point-of-care testing devices and testing for quantitative as well as qualitative measurement of cross-linked fibrin degradation products is a factor expected to support growth of the global D-dimer test market over the forecast period.
However, product recalls and poorly developed medical infrastructure are some factors expected to hamper growth of the target market over the forecast period.
Increasing initiatives and investments by various governments and leading organizations to improve health care infrastructure is expected to create lucrative opportunities for prominent players operating in the market.
Global D-Dimer Test Market: Market Forecast
The comprehensive research report comprises a complete forecast of the global D-dimer test market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global D-dimer test market is expected to expand at a moderate CAGR of 5.3% during the forecast period.
Global D-Dimer Test Market: Segmental Snapshot
The market report has been segmented on the basis of testing method, end user, and countries. The testing method segment includes point-of-care testing and laboratory testing (Coagulation analyzers and clinical chemistry analyzers). The disease type segment includes deep vein thrombosis, pulmonary embolism, and disseminated intravascular coagulation. The end user segment includes hospitals, clinics, research institutes, diagnostics laboratories, home, assisted living healthcare facilities, and ambulatory surgical centers. The region covered in the analysis are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
By Testing Method: The laboratory testing segment accounted for highest revenue share contribution, and is expected to maintain its dominance over the forecast period. The point-of-care testing segment is projected to register highest CAGR of over 5.2% over the forecast period.
By Disease Type: The deep vein thrombosis segment accounted for highest revenue share contribution and is expected to maintain its dominance over the forecast period. The hospitals segment is projected to register highest CAGR of over 5.3% over the forecast period.
By End User: The hospitals segment accounted for highest revenue share contribution and is expected to maintain its dominance over the forecast period. The hospitals segment is projected to register highest CAGR of over 5.3% over the forecast period.
By Region: The market in North America accounted for highest revenue share in the global D-dimer test market in 2019 whereas the Asia Pacific market is projected to register highest CAGR of over 5.5% over the forecast period.
Global D-Dimer Test Market: Competitive Analysis
The research report on the global D-dimer test market includes profiles of some of major companies such as Abbott Laboratories, Danaher Corp. (Beckman Coulter, Inc.), Bio-Rad Laboratories, Inc., Roche Holding AG (F. Hoffmann-La Roche Ltd.), Siemens Healthineers AG, Helena Laboratories Corporation (Helena Laboratories (UK) Limited), Sysmex Corporation, bioMérieux S.A., WerfenLife, S.A. (Instrumentation Laboratory Company), and HORIBA, Ltd.
The Global D-Dimer Test Market: Europe Industry, Size, Share, Growth, Trends, and Forecast, 2019–2028 report has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global D-dimer test market for 2019–2028.
MarketResearch.biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. MarketResearch.biz offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.